PRECIGEN INC
NASDAQ: PGEN (Precigen, Inc.)
Kemas kini terakhir: 8 jam lalu8.54
0.33 (4.02%)
| Penutupan Terdahulu | 8.21 |
| Jumlah Dagangan | 6,361,552 |
| Harga / Pendapatan (P/E Ke hadapan) | 16.89 |
| Harga / Jualan (P/S) | 32.22 |
| Harga / Buku (P/B) | 61.05 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -1,685.01% |
| EPS Cair (TTM) | -0.550 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 25.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 35.04% |
| Nisbah Semasa (MRQ) | 3.53 |
| Aliran Tunai Operasi (OCF TTM) | -70.41 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.20 M |
| Pulangan Atas Aset (ROA TTM) | -44.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -278.55% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Precigen, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.83 |
|
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 10.56% |
| % Dimiliki oleh Institusi | 67.08% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Patient Capital Management, Llc | 30 Jun 2026 | 19,036,976 |
| Occam Crest Management Lp | 30 Jun 2026 | 3,605,941 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| THOMASIAN HARRY JR. | - | - | 0 | 0 |
| Jumlah Keseluruhan Kuantiti Bersih | 0 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 0 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| THOMASIAN HARRY JR. | Pegawai | 23 Sep 2026 | Pelaksanaan pilihan | 53,665 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |